Cylindroma

Overview

4 out of 5 (2 Reviews)

Credits

1.50

Post Assessment Questions

11

Start Date

1 Sep 2023

Last Review Date

1 Mar 2024

Expiration Date

31 Aug 2026

Estimated Time To Finish

90 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Cylindromas, or cutaneous cylindromas, are rare, distinct adnexal neoplasms characterized by a dual lineage proliferation of cells nestled within the dermis. These neoplasms are predominantly derived from likely apocrine cells in the dermis within the hair follicle bulge. Upon cross-sectional examination, cylindromas exhibit a round morphology akin to cylinders, hence their nomenclature, reflecting their cylindrical shape. Although cylindromas are typically slow-growing and manifest as diminutive entities, they are generally benign. However, exceedingly rare instances of malignant transformation and potential metastases have been reported, especially in conjunction with multiple lesions associated with Brooke-Spiegler syndrome.

Cylindromas are slow-growing lesions primarily found on the scalp or face of individuals. They exhibit a marked predilection toward females, occurring approximately 9 times more frequently than males. When multiple cutaneous cylindromas congregate on the scalp, they can amalgamate, creating an appearance reminiscent of headgear like a hat or turban. Recognizing the intricate association between cylindromas and spiradenomas is imperative, as they share close ties and are associated with various genetic syndromes characterized by undifferentiated neoplasms stemming from apocrine lineage. This activity provides a comprehensive overview of cylindromas, covering their etiology, epidemiology, diagnosis, and management, thereby offering a multifaceted approach to understanding this condition. This activity highlights the pivotal role of interdisciplinary collaboration among healthcare professionals, emphasizing the significance of cohesive management strategies to address this unique and rare cutaneous condition.


UAN: JA4008338-0000-23-1331-H01-P

Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Recognize the clinical features and presentation of cylindroma lesions, including their slow-growing nature and predominance on the scalp and face.

  • Implement pretreatment embolization techniques into surgical management plans for patients with sizable or multiple cylindroma lesions to reduce intraoperative bleeding.

  • Select appropriate genetic testing modalities and referral pathways for patients suspected of having Brooke-Spiegler syndrome based on clinical presentation and family history.

  • Collaborate with interprofessional healthcare providers to optimize the diagnostic and management approach for patients with cylindroma lesions to achieve optimal outcomes.

Pharmacy Activity Type:
Disease/Drug Therapy Related


Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Pharmacists: StatPearls, LLC designates this activity for a maximum of 1.50 ACPE credit(s). (UAN: JA4008338-0000-23-1331-H01-P ). Pharmacists should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Emily E. on 2/27/2022

Sikander A. on 2/21/2024

Unlimited Pharmacist CE

Stay up to date on the latest medical knowledge with 6673 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7924.5 hours of CE.

Single Activity

Take this single activity

$43.50 1 activity

6 Month Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$119 per half year per user

1 Year Unlimited Pharmacist CE

Access to all the Unlimited Pharmacist CE activities in all specialties.

$199 per 1 year per user